In this context, the study published by Hamakawa et al. demonstrated that the number of DNA fragments that harbour cancer-specific somatic mutations in the TP53 gene (tDNA) did not correlate with the total level of cfDNA and that only tDNA showed a correlation with disease status in GC patients [9]. Here, TP53 is linked to cancer.